Download FREE Report Sample
Download Free sampleIntravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Intravitreal Injectable Market contains market size and forecasts of Intravitreal Injectable in global, including the following market information:
Global Intravitreal Injectable Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Intravitreal Injectable Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Intravitreal Injectable companies in 2021 (%)
The global Intravitreal Injectable market was valued at 14950 million in 2021 and is projected to reach US$ 23690 million by 2028, at a CAGR of 6.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-VEGF Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech and Kanghong Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intravitreal Injectable manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravitreal Injectable Market, by Drug, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravitreal Injectable Market Segment Percentages, by Drug, 2021 (%)
Anti-VEGF
Steroids
Others
Global Intravitreal Injectable Market, by Disease, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravitreal Injectable Market Segment Percentages, by Disease, 2021 (%)
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Global Intravitreal Injectable Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Intravitreal Injectable Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravitreal Injectable revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Intravitreal Injectable revenues share in global market, 2021 (%)
Key companies Intravitreal Injectable sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Intravitreal Injectable sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
